WEC
ORGS

Winslow Evans & Crocker’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Winslow Evans & Crocker’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-100
Closed -$6K – 1367
2019
Q1 		$6K Hold
100
– – ﹤0.01% 971
2018
Q4 		$6K Hold
100
– – ﹤0.01% 906
2018
Q3 		$6K Hold
100
– – ﹤0.01% 929
2018
Q2 		$10K Hold
100
– – ﹤0.01% 818
2018
Q1 		$10.3K Buy
+100
New +$11.8K ﹤0.01% 779

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCM
Venator Capital Management Toronto, Ontario, Canada $48.7M AUM 87.97% 1-Year Est. Return
DG
Delek Group Herzliya, Israel $2.59B AUM 1.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.25B AUM 19.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TFGT
TS Financial Group (TSFG) Lake Forest, Illinois $794M AUM 24.65% 1-Year Est. Return

Winslow Evans & Crocker's ORGS Position: Q2 2019 in Review

Winslow Evans & Crocker sold out of Orgenesis Inc. Common Stock (ORGS) in Q2 2019, closing a stake of 100 shares — an estimated $6K sold.

Winslow Evans & Crocker first reported a position in ORGS in Q1 2018 and held it in 5 quarters. The position peaked at $10.3K in Q1 2018. 16 funds tracked by Wall St. Rank hold ORGS as of Q2 2019.

  • Winslow Evans & Crocker reported no remaining Orgenesis Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Winslow Evans & Crocker sold 100 Orgenesis Inc. Common Stock shares in Q2 2019, an estimated $6K.
  • Winslow Evans & Crocker first reported a position in Orgenesis Inc. Common Stock in Q1 2018 and held it in 5 quarters.
  • Winslow Evans & Crocker's Orgenesis Inc. Common Stock position peaked at $10.3K in Q1 2018.
  • 16 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q2 2019.

Based on Winslow Evans & Crocker's 13F filing for Q2 2019, filed 19 Jul 2019.